Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study

Yitao Zheng,1,2,* Yanjun Xiang,3,* Hongqi Shi,2,* Zhuoqun Lin,2 Shuqun Cheng,3 Jiuting Zhu1 1Department of Pancreatic and Gastrointestinal Surgery Division, Ningbo No.2 Hospital, Ningbo, People’s Republic of China; 2Department of Hepatological Surgery, the First Affiliated Ho...

Full description

Bibliographic Details
Main Authors: Zheng Y, Xiang Y, Shi H, Lin Z, Cheng S, Zhu J
Format: Article
Language:English
Published: Dove Medical Press 2024-06-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
atezolizumab
bevacizumab
hepatocellular carcinoma
prognosis
transarterial chemoembolization
Online Access:https://www.dovepress.com/transarterial-chemoembolization-combined-with-atezolizumab-plus-beva-2-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/transarterial-chemoembolization-combined-with-atezolizumab-plus-beva-2-peer-reviewed-fulltext-article-JHC

Similar Items